This medicine represents the single greatest therapeutic advancement in the history of CF, offering a treatment for the underlying cause of the disease that could eventually benefit more than 90 percent of people with CF.
Legislation Would Increase Patient and Expert Participation in FDA Review of Rare Disease Treatments
April 25, 2012
|
3 min read
New Effort Will Search for Potential Therapies Targeting the Most Common Mutation of Cystic Fibrosis
Nov. 16, 2011
|
4 min read
CF Foundation's $1 Million Investment Helped Drug Known as Cayston® Become a Reality
Feb. 22, 2010
|
4 min read
Galapagos and Cystic Fibrosis Foundation Therapeutics Sign €1.3 million* Agreement
April 14, 2005
|
4 min read
Cystic Fibrosis Foundation Therapeutics to Provide Alnylam with $1.5 Million in Funding for Discovery Efforts
March 16, 2005
|
5 min read